#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neutropenia Anal cancer Nasopharyngeal cancer Heavy menstrual bleeding Crigler-Najjar syndrome Friedreich's ataxia Deafness bilateral Langerhans cell sarcoma Neuroendocrine tumour Glomerulonephritis chronic Primary adrenal insufficiency Familial dilated cardiomyopathy Renal cancer metastatic Intracranial calcification Ewing's sarcoma More trials…

    Learn about Rare Diseases

    Pelizaeus-Merzbacher disease – Trials in Disease Phenylketonuria – Treatment Osteosarcoma metastatic – Trials in Disease Cerebral arteriovenous malformation haemorrhagic – Trials in Disease Mantle cell lymphoma stage III – Life with Disease Skin angiosarcoma – Treatment Synovial sarcoma metastatic – Treatment Primary mediastinal large B-cell lymphoma – Treatment Hairy cell leukaemia – Trials in Disease Isodicentric chromosome 15 syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Oxybate [14C]ZIPALERTINIB Resatorvid Etravirine Thiamine Nitrate Bp ARFOLITIXORIN Tildacerfont Phleum Pratense Pollen Extract Pitavastatin Calcium [18F]CPFPX Cetrelimab RUBIDIUM CHLORIDE Imifoplatin Vanglusagene Ensiparvovec GS-1720 Milnacipran Hydrochloride Bbp-398 Mitomycin Pimozide Petosemtamab More therapies…

    Learn about Your Condition

    Lung disorder Benign prostatic hyperplasia Hypoparathyroidism Testicular germ cell tumour Retinopathy proliferative Hyperlipidaemia Ejection fraction normal Chondrocalcinosis Craniotomy Bone marrow failure Milk allergy Propionic acidaemia Liposarcoma recurrent Immunodeficiency congenital Marfan's syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of dexamethasone effectiveness in reducing complications and mortality in patients with severe burns

    Recruiting

    3 1 1
    Investigated Diseases:
    • Thermal burn
    Investigated Drugs:
    • Dexamethasone Phosphate
    • Sodium Chloride
    France

  • Study on Ivosidenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed IDH1-Mutated Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Ivosidenib
    • Azacitidine
    • Venetoclax
    Austria Belgium Denmark Estonia Finland France +8

  • Study on Inhaled Molgramostim for Children with Autoimmune Pulmonary Alveolar Proteinosis

    Recruiting

    3 1 1
    Investigated Drugs:
    • Molgramostim
    Germany

  • Study on the Effects of EH-301, N-Acetylcysteine, and Riluzole in Patients with Amyotrophic Lateral Sclerosis (ALS)

    Recruiting

    1 1 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • Acetylcysteine
    • Riluzole
    Spain

  • Study on the Safety and Effects of Lutetium Lu-177 and ABY-271 in Patients with HER2-Positive Metastatic Breast Cancer

    Recruiting

    1 1 1
    Investigated Diseases:
    • HER2 positive breast cancer
    Investigated Drugs:
    • ABY-271
    • LUTETIUM LU-177
    Belgium Germany Norway Sweden

  • Study on Clobetasol, Mometasone, and Tacrolimus for Treating Vulvar Lichen Sclerosus in Children

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Lichenoid keratosis
    • Lichen sclerosus
    Investigated Drugs:
    • Clobetasol Propionate
    • Mometasone Furoate
    • Tacrolimus
    Poland
Previous Page
1 … 227 228 229 230 231 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!